TY  - JOUR

T1  - Surprise phase III failure for ZD1839

JO  - The Lancet Oncology

UR  - https://doi.org/10.1016/s1470-2045(02)00883-5

PY  - 2002/10/01

AU  - Wilkinson E

ED  - 

DO  - DOI: 10.1016/s1470-2045(02)00883-5

PB  - Elsevier BV

VL  - 3

IS  - 10

SP  - 583

EP  - 583

Y2  - 2025/11/30

ER  -